China Traditional Chinese Medicine Holdings Co. Limited
CHIZF
$0.27
-$0.07-20.85%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.29% | -9.86% | -10.46% | -7.94% | -6.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.29% | -9.86% | -10.46% | -7.94% | -6.47% |
| Cost of Revenue | -5.31% | -4.54% | -3.87% | -3.63% | -4.51% |
| Gross Profit | -13.28% | -15.06% | -16.75% | -12.08% | -8.36% |
| SG&A Expenses | -10.67% | -11.94% | -13.17% | -7.51% | -2.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 25.23% | 47.59% | 65.72% | 27.39% | -35.26% |
| Total Operating Expenses | -7.59% | -7.59% | -7.64% | -5.20% | -3.83% |
| Operating Income | -38.89% | -42.64% | -45.36% | -40.56% | -36.71% |
| Income Before Tax | -126.90% | -102.82% | -87.03% | -58.59% | -27.11% |
| Income Tax Expenses | 166.05% | 175.15% | 185.37% | -2,863.34% | -205.05% |
| Earnings from Continuing Operations | -133.83% | -113.14% | -98.60% | -57.22% | 4.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 192.96% | 155.32% | 129.82% | 57.72% | -663.34% |
| Net Income | -128.95% | -109.58% | -95.92% | -57.20% | -5.20% |
| EBIT | -38.89% | -42.64% | -45.36% | -40.56% | -36.71% |
| EBITDA | -17.67% | -22.40% | -26.38% | -24.02% | -22.62% |
| EPS Basic | -129.37% | -109.84% | -96.11% | -57.37% | -5.26% |
| Normalized Basic EPS | -11.11% | -26.17% | -35.71% | -42.65% | -48.68% |
| EPS Diluted | -129.37% | -109.84% | -96.11% | -57.37% | -5.26% |
| Normalized Diluted EPS | -11.11% | -26.17% | -35.71% | -42.65% | -48.68% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -1.00% | -1.00% |